Results 211 to 220 of about 178,132 (320)

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Quality of life assessment instruments for radiodermatitis in cancer patients: scoping review. [PDF]

Rev Lat Am Enfermagem
Lopes LM, Neiva BN, Aguiar BRL, Gomes P, Ferreira EB, Reis PEDD.   +5 more
europepmc   +1 more source

Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate whether add‐on memantine would exacerbate seizures in people with epilepsy. Methods This was a prospective cohort study. People with epilepsy diagnosed with cognitive impairment were consecutively invited. Those who agreed were followed up for at least 24 weeks.
Peiyu Wang, Lu Lu, Hui Gao, Qi Zhang, Jing Xiao, Josemir W. Sander, Weixi Xiong, Dong Zhou   +7 more
wiley   +1 more source

Exercise prescriptions for patients on hemodialysis in Brazil: a scoping review. [PDF]

J Bras Nefrol
Ribeiro HS, Andrade FP, Leal DV, Oliveira JS, Wilund KR, Reboredo MM, Viana JL.   +6 more
europepmc   +1 more source

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang, Jianli Zhao, Xue Zhao, Xiaowei Hu, Zichun Xiao, Jie Wu, Xiaowen Li, Jing Xu, Yu‐Jing Li   +8 more
wiley   +1 more source

Prophylactic dressings for preventing nasal pressure ulcer in premature newborns: an effectiveness review. [PDF]

Rev Esc Enferm USP
Viero CM, Alves PJP, Munhoz OL, Cabral TS, Galvão CM, Costa VZD, Eberhardt TD, Franco MS, Lima SBS.   +8 more
europepmc   +1 more source

Age‐Related Characteristics of SYT1‐Associated Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives We describe the clinical manifestations and developmental abilities of individuals with SYT1‐associated neurodevelopmental disorder (Baker‐Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations ...
Sam G. Norwitz, Josefine Eck, Joel S. Winston, Kate Baker   +3 more
wiley   +1 more source

Development of venous thromboembolism and its impact on hospitalized adults with covid-19: rapid systematic review. [PDF]

J Vasc Bras
Rocha AP, Sanchez JG.
europepmc   +1 more source

Bortfald af Revisionspligt - RS 2405 [PDF]

, 2004
Mehlsen, Camilla, Nielsen, Jacob Alkier
core  

Doing Experiments and Revising Rules with Natural Language and Probabilistic Reasoning [PDF]

Top Piriyakulkij, Kevin Ellis
openalex   +1 more source